Coriell Life Sciences is expert in advising physicians on how to use genomics to understand what medications will work for their patients and which will cause harm. Through partnerships with IBM and sequencing laboratories, CLS has developed an entirely SaaS based platform for drug efficacy reporting that is inexpensive, reimbursed by MediCare and most carriers and provides immediate patient outcome benefit and financial savings.